Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways
- PMID: 20026325
- DOI: 10.1016/j.exer.2009.12.004
Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways
Abstract
Increased tear osmolarity is an essential feature of dry eye disease. Curcumin, a natural polyphenol extracted from herb turmeric, has recently been reported to have anti-inflammatory effects. However, its anti-inflammatory effects have not been investigated in dry eye disease. It has been reported that elevated osmolarity achieved by adding sodium chloride to the culture medium of corneal epithelial cells increased the production of IL-1beta, a proinflammation cytokine. This in vitro dry eye model was used to test the anti-inflammatory effects of curcumin. In the present study, a 450 mOsM hyperosmotic medium was produced by adding sodium chloride to the culture medium to reach a final concentration of 90mM. Human corneal epithelial cells cultured in this hyperosmotic medium for 24h showed an increase of IL-1beta, IL-6 and TNF-alpha levels in the conditioned medium. IL-1beta was also upregulated at mRNA levels. Activation of p38 MAP kinase (p38), JNK MAP kinase (JNK) and NF-kappaB in cultured corneal epithelial cells were also induced by hyperosmotic conditions. Curcumin at concentrations of 1-30muM did not affect the cell viability of cultured corneal epithelial cells. Pretreatment of curcumin (5muM) completely abolished the increased production of IL-1beta induced by the hyperosmotic medium. Increased phosphorylation of p38 caused by high osmolarity was also completely abolished by curcumin, whereas the phosphorylation of JNK was only partially inhibited. SB 203580 (p38 inhibitor), but not SP 600125 (JNK inhibitor), completely suppressed hyperosmoticity-induced IL-1beta production, indicating that the inhibition of production of IL-1beta by curcumin may be achieved through the p38 signal pathway. Curcumin completely abolished a hyperosmoticity-induced increase of NF-kappaB p65. NF-kappaB inhibitor suppressed hyperosmoticity-induced IL-1beta production. p38 inhibitor suppressed hyperosmoticity-induced NF-kappaB activation, indicating that NF-kappaB activation was dependent on p38 activation. The present study suggests that curcumin might have therapeutic potential for treating dry eye disease.
Similar articles
-
Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.Int J Mol Med. 2007 May;19(5):757-63. Int J Mol Med. 2007. PMID: 17390080
-
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.Exp Eye Res. 2006 Sep;83(3):526-35. doi: 10.1016/j.exer.2006.02.004. Epub 2006 Apr 27. Exp Eye Res. 2006. PMID: 16643899
-
Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells.Exp Eye Res. 2001 Jul;73(1):111-21. doi: 10.1006/exer.2001.1019. Exp Eye Res. 2001. PMID: 11428868
-
Impact of curcumin on p38 MAPK: therapeutic implications.Inflammopharmacology. 2023 Oct;31(5):2201-2212. doi: 10.1007/s10787-023-01265-2. Epub 2023 Jul 27. Inflammopharmacology. 2023. PMID: 37498375 Review.
-
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.Med Res Rev. 2001 Mar;21(2):129-45. doi: 10.1002/1098-1128(200103)21:2<129::aid-med1003>3.0.co;2-h. Med Res Rev. 2001. PMID: 11223862 Review.
Cited by
-
Effects of Lutein on Hyperosmoticity-Induced Upregulation of IL-6 in Cultured Corneal Epithelial Cells and Its Relevant Signal Pathways.J Ophthalmol. 2016;2016:8341439. doi: 10.1155/2016/8341439. Epub 2016 Mar 7. J Ophthalmol. 2016. PMID: 27047687 Free PMC article.
-
Curcumin: a modulator of inflammatory signaling pathways in the immune system.Inflammopharmacology. 2019 Oct;27(5):885-900. doi: 10.1007/s10787-019-00607-3. Epub 2019 May 28. Inflammopharmacology. 2019. PMID: 31140036 Review.
-
Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities.Molecules. 2025 Jan 21;30(3):457. doi: 10.3390/molecules30030457. Molecules. 2025. PMID: 39942561 Free PMC article. Review.
-
Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells.Mol Vis. 2010 Sep 12;16:1864-73. Mol Vis. 2010. PMID: 21031020 Free PMC article.
-
Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.Clin Ophthalmol. 2010 Oct 21;4:1201-6. doi: 10.2147/OPTH.S13271. Clin Ophthalmol. 2010. PMID: 21060672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials